Baseline prostate specific antigen does not affect the efficacy of tamsulosin in patients with lower urinary tract symptoms/benign prostatic hyperplasia

Author： Speakman M.J.   Snijder J.R.   Anthonijs G.L.   Doyle C.A.  

Publisher： Elsevier

ISSN： 1569-9056

Source： European Urology Supplements, Vol.2, Iss.1, 2003-02, pp. : 159-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tamsulosin is effective in patients with lower urinary tract symptoms/benign prostatic hyperplasia, irrespective of prostate size

By Speakman M.J.   Snijder J.R.   Anthonijs G.L.   Doyle C.A.   Carter A.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 75-75

Elsevier

Access to resources Recommend Favorite

Relationship between benign prostatic hyperplasia and lower urinary tract symptoms and correlation between prostate volume and serum prostate-specific antigen in clinical routine

By Hedelin Hans   Johansson Niklas   Ströberg Peter  

Scandinavian Journal of Urology and Nephrology, Vol. 39, Iss. 2, 2005-04 ,pp. : 154-159

Informa Healthcare

Access to resources Recommend Favorite

Identifying Patients with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) at Risk for Progression

By Jimenez-Cruz F.  

European Urology Supplements, Vol. 2, Iss. 7, 2003-11 ,pp. : 6-12

Elsevier

Access to resources Recommend Favorite

Achieving the Total Approach in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Management

By O'Leary M.  

European Urology Supplements, Vol. 2, Iss. 7, 2003-11 ,pp. : 25-33

Elsevier

Access to resources Recommend Favorite

The Total Approach in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Management: Introduction and Conclusions

By Chapple C.R.  

European Urology Supplements, Vol. 2, Iss. 7, 2003-11 ,pp. : 1-5

Elsevier

Access to resources Recommend Favorite